Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,842 | -104,793 | -75,959 | -43,798 | -22,287 |
| Depreciation Amortization | 230 | 852 | 613 | 392 | 167 |
| Accounts receivable | 31 | 21 | 52 | 43 | 48 |
| Accounts payable and accrued liabilities | 326 | -420 | -1,348 | 2,858 | 2,522 |
| Other Working Capital | 4,323 | -9,413 | 518 | -8,000 | 4,266 |
| Other Operating Activity | 3,281 | 11,472 | 8,900 | 1,791 | -425 |
| Operating Cash Flow | $-19,650 | $-102,280 | $-67,224 | $-46,714 | $-15,709 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -861 | -824 | -715 | -520 |
| Purchase Of Investment | -32,644 | -514,308 | -231,146 | -93,671 | -71,143 |
| Sale Of Investment | 42,216 | 153,390 | 121,128 | 29,128 | 4,959 |
| Investing Cash Flow | $9,568 | $-361,779 | $-110,842 | $-65,258 | $-66,705 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 164 | 450,650 | 450,314 | 122,344 | 122,184 |
| Other Financing Activity | 0 | -756 | -745 | -279 | -293 |
| Financing Cash Flow | $164 | $449,894 | $449,569 | $122,065 | $121,891 |
| Beginning Cash Position | 47,159 | 61,325 | 61,325 | 61,325 | 61,325 |
| End Cash Position | 37,241 | 47,159 | 332,828 | 71,418 | 100,802 |
| Net Cash Flow | $-9,919 | $-14,166 | $271,503 | $10,093 | $39,477 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,650 | -102,280 | -67,224 | -46,714 | -15,709 |
| Capital Expenditure | -4 | -861 | -824 | -715 | -520 |
| Free Cash Flow | -19,654 | -103,141 | -68,048 | -47,429 | -16,230 |